PPARG and urinary bladder carcinoma: It was found that ISO down-regulated the expression of PPARγ, PTEN, AKT, and CA9 proteins in the PPARγ/PTEN/AKT signaling pathway in bladder cancer cells, inhibited the activity of proliferation-related proteins, and thus, inhibited the occurrence and progression of bladder cancer [17].